Hunan Hansen Pharmaceutical Co Ltd 002412.SZ

Last Updated: May 15, 12:00 AM·SZSE

Hunan Hansen Pharmaceutical Co Ltd

Hunan Hansen Pharmaceutical Co Ltd. Stock Analysis 002412.SZ

China Health Care Small Cap
Hunan Hansen Pharmaceutical Co. Ltd. engages in the research, development, production, manufacture, and sales of traditional Chinese medicines. The company is headquartered in Yiyang, Hunan. The company went IPO on 2010-05-25. The firm's main products include Simotang oral liquid, used for abdominal distention and phlegmatic abdominalgia; Yushangling capsules, used for injuries from falls; Yinxingye capsules, used for stroke and chest distress, as well as Suoquan capsules, used for kidney deficiency and others.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.